223 related articles for article (PubMed ID: 15492914)
1. The effect of Helicobacter pylori eradication in patients with functional dyspepsia: assessment of different diagnostic tests.
Cinar K; Soykan I; Ozden A
Turk J Gastroenterol; 2004 Sep; 15(3):159-63. PubMed ID: 15492914
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
[TBL] [Abstract][Full Text] [Related]
3. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
[TBL] [Abstract][Full Text] [Related]
4. Bismuth-based therapies for the first step eradication of Helicobacter pylori.
Sezgin O; Altintaş E; Uçbilek E; Tataroğlu C
Turk J Gastroenterol; 2006 Jun; 17(2):90-3. PubMed ID: 16830288
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Koskenpato J; Färkkilä M; Sipponen P
Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
[TBL] [Abstract][Full Text] [Related]
6. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
Liu Q; Qi D; Kang J; Jin Y; Liu W; Gao W; Hou P; Lu J
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):221-5. PubMed ID: 25629566
[TBL] [Abstract][Full Text] [Related]
8. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
9. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
[TBL] [Abstract][Full Text] [Related]
10. Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients.
Wei Z; Ying L; Wen G; Mengnan Z; Yali Z
Helicobacter; 2014 Apr; 19(2):124-8. PubMed ID: 24617669
[TBL] [Abstract][Full Text] [Related]
11. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
12. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial.
Svoboda P; Kantorová I; Ochmann J; Doubek J; Kozumplík L; Marsová J
Hepatogastroenterology; 1997; 44(15):886-90. PubMed ID: 9222709
[TBL] [Abstract][Full Text] [Related]
13. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
14. [Detection of Helicobacter pylori and antimicrobial resistance in gastric biopsy specimens].
Cağdaş U; Otağ F; Tezcan S; Sezgin O; Aslan G; Emekdaş G
Mikrobiyol Bul; 2012 Jul; 46(3):398-409. PubMed ID: 22951652
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
17. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
Kyzekova J; Mour J
Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
[TBL] [Abstract][Full Text] [Related]
18. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Talley NJ; Vakil N; Ballard ED; Fennerty MB
N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
[TBL] [Abstract][Full Text] [Related]
19. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
20. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Gisbert JP; Gisbert JL; Marcos S; Jimenez-Alonso I; Moreno-Otero R; Pajares JM
Aliment Pharmacol Ther; 2008 Feb; 27(4):346-54. PubMed ID: 17999716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
